Leticia Cortez Neto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Leticia Cortez Neto has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Carla Gentile Matas
Universidade de São Paulo, Faculdade de Medicina, Departamento de Fisioterapia, Fonoaudiologia e Terapia Ocupacional, São Paulo SP, Brazil
1 shared publication - Jéssica Sales Vosgrau
Univ Sao Paulo, Fac Med FMUSP, Dept Phys Therapy Speech Language Pathol & Audiol, Sao Paulo, SP, Brazil
1 shared publication - Nayara Pereira Santos
Universidade de São Paulo, Brazil
1 shared publication - Renata Aparecida Leite
Universidade de São Paulo, Brasil
1 shared publication - Sandro Luiz de Andrade Matas
Department of Neurology and Neurosurgery, Escola Paulista de Medicina, Federal University of São Paulo (UNIFESP), São Paulo, Brazil
1 shared publication Vicente Odone Filho
Universidade de São Paulo, Faculdade de Medicina, Departamento de Pediatria, São Paulo SP, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 February 2020
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 78 (2) , 63-69
Brainstem auditory pathway of children with acute lymphoid leukemia on chemotherapy with methotrexate
Objective: Investigate the auditory pathway in the brainstem of children with acute lymphoblastic leukemia submitted to chemotherapy (by intravenous or intrathecal infusion). Methods: Fourteen children aged between 2 and 12 years with diagnosis of acute lymphoid leukemia were evaluated. The following procedures were used: meatoscopy, acoustic immitance measurements, tonal audiometry, vocal audiometry, transient otoacoustic emissions, and auditory brainstem response. Results: From the 14 children with normal auditory thresholds, 35.71% showed an alteration in auditory brainstem response, with a predominance of hearing impairment in the lower brainstem. It was found that 80% of the children with alteration had used intrathecal methotrexate less than 30 days and that 40% had the highest cumulative intravenous methotrexate doses. Conclusion: Children with acute lymphoblastic leukemia submitted to chemotherapy, present auditory pathway impairment in the brainstem, with a predominance of a low brainstem.
- 1 February 2020
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 78 (2) , 63-69
Open AccessBrainstem auditory pathway of children with acute lymphoid leukemia on chemotherapy with methotrexate
Objective: Investigate the auditory pathway in the brainstem of children with acute lymphoblastic leukemia submitted to chemotherapy (by intravenous or intrathecal infusion). Methods: Fourteen children aged between 2 and 12 years with diagnosis of acute lymphoid leukemia were evaluated. The following procedures were used: meatoscopy, acoustic immitance measurements, tonal audiometry, vocal audiometry, transient otoacoustic emissions, and auditory brainstem response. Results: From the 14 children with normal auditory thresholds, 35.71% showed an alteration in auditory brainstem response, with a predominance of hearing impairment in the lower brainstem. It was found that 80% of the children with alteration had used intrathecal methotrexate less than 30 days and that 40% had the highest cumulative intravenous methotrexate doses. Conclusion: Children with acute lymphoblastic leukemia submitted to chemotherapy, present auditory pathway impairment in the brainstem, with a predominance of a low brainstem.